Accelerated phase chronic myelogenous leukemia

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Aman vibhore
Classification and external resources
Specialty Hematology and oncology
MeSH D015465

Accelerated phase chronic myelogenous leukemia is a phase of chronic myelogenous leukemia in which the disease is progressing.[1] In this phase, 10 to 19 % of the cells in the blood and bone marrow are blast cells (immature blood cells). In the accelerated phase, these leukemia cells grow quickly.

Symptoms[edit]

Common symptoms include fever, bone pain, and swollen spleen.[2]

Treatment[edit]

Patients treated with imatinib, dasatinib, and nilotinib have shown meaningful rates of hematologic and cytogenetic response.[3]

Prognosis[edit]

Prognosis is very poor once chronic myelogenous leukemia reaches the accelerated phase; it behaves similarly to acute myeloid leukemia.

References[edit]

  1. ^ Moshe Talpaz (2002). "Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study". Blood 99 (6): 1928–1937. doi:10.1182/blood.v99.6.1928. 
  2. ^ "Chronic myelogenous leukemia (CML)". 
  3. ^ Shah, NP (Mar 2008). "Advanced CML: therapeutic options for patients in accelerated and blast phases.". Journal of the National Comprehensive Cancer Network : JNCCN. 6 Suppl 2: S31–S36. PMID 18397679. 

External links[edit]